January 20, 2025. T-CURX will attend the Advanced Therapies Week 2025 in Dallas, TX

Ulf Grawunder, CEO of T-CURX, will present an update on T-CURX CAR-T development activities at Phacilitate's U.S. flagship event, the Advanced Therapies Week 2025 taking place from Jan 20-23, 2025 in Dallas, TX, U.S.A.

T-CURX' CEO, Ulf Grawunder, PhD, will attend the 2025 Advanced Therapies Week (https://advancedtherapiesweek....) taking place from Jan 20-23 at the Kay Bailey Hutchison Convention Center Dallas, Texas, U.S.A.

The Advanced Therapies Week at the beginning of the year is Phacilitate's flagship event in the U.S., focusing on innovations in the field of Cell and Gene Therapy. More than 2'500 attendees from more than 600 Biotech companies, 180 exhibitors, 100 investors and 250 speakers from the industry are expected to attend this year's event

Ulf Grawunder, will have two presentations at the conference. First, he will present an update on the company's CAR-T development activities, including technology development and CAR-T pipeline products in the "Seed Investment Pitch" session taking place on Jan 21, from 3:30-4:30 p.m. taking place in the Innovation Zone . Second, he will give a presentation about "Promises and Challenges for in vivo CAR-T development" in the "In vivo Therapeutics" session taking place on Jan 23, from 11:45 a.m. to 12:45 p.m. in Theater 4 (Therapeutic Advances).